Flexion announces plans to price $60 million public sale of its stock

Joint bookrunners Wells Fargo, RBC Capital and BMO Capital to assist

By Devika Patel

Knoxville, Tenn., June 7 – Flexion Therapeutics Inc. will conduct a $60 million public offering of common stock with a 30-day greenshoe for $9 million additional shares, according to a preliminary prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Wells Fargo Securities LLC, RBC Capital Markets and BMO Capital Markets are the bookrunners.

Proceeds will be used for general corporate purposes.

The Burlington, Mass., specialty pharmaceutical company develops injectable pain therapies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.